Sort
64,565 grants matching “drug discovery”
Studies of DNA Licensing in Apicomplexa Parasites
$538,527Michael W White · University Of South Florida · R01 · FY2016 · AI
High Throughput Screening for Non-antibiotic inhibitors of Clostridium difficile Pathophysiology
$538,467Julian G Hurdle · Texas A&M University Health Science Ctr · R01 · FY2021 · AI
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection
$538,447Yuanpu Peter Di · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AI
Evolutionary potential of HIV-1 capsid: mechanisms and consequences
$538,362Masahiro Yamashita · Columbia University Health Sciences · R01 · FY2023 · AI
Functional Analysis of Natural Variation in the Pathogen Candida albicans
$538,362Aaron P Mitchell · University Of Georgia · R01 · FY2020 · AI
Identification of Small Molecules that Influence Trafficking of the GnRH Receptor
$538,346Jo Ann Janovick · Texas Tech University Health Scis Center · R01 · FY2018 · DK
Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria
$538,322Zoltan N. Oltvai · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · AI
Mechanisms controlling the efficiency of hemostatic vitamin K-dependent protein activation
$538,321Kathleen Lucile Berkner · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · HL
Project 3: From Networks and Structures to Hierarchical Whole Cell Models of Cancer
$538,261Trey Ideker · University Of California, San Francisco · U54 · FY2022 · CA
Mining the Coprophilous Mycobiome for New Cryptococcus Antiinfectives and Antifungal Synergists
$538,220James B Gloer · University Of Iowa · R01 · FY2017 · GM
Discovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AML
$538,185Muxiang Zhou · Emory University · R01 · FY2025 · CA
Non Alcoholic Steatohepatitis Clinical Research Network
$538,178Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2019 · DK
Coordinate Regulation of Bacterial Virulence Factors
$538,137John J Mekalanos · Harvard Medical School · R01 · FY2016 · AI
Coordinate Regulation of Bacterial Virulence Factors
$538,137John J Mekalanos · Harvard Medical School · R01 · FY2015 · AI
Coordinate Regulation of Bacterial Virulence Factors
$538,137John J Mekalanos · Harvard Medical School · R01 · FY2017 · AI
Coordinate Regulation of Bacterial Virulence Factors
$538,137John J Mekalanos · Harvard Medical School · R01 · FY2014 · AI
Recyclable Magnetic Co/C Hybrid ROMP Reagents, Scavengers and Ligands
$538,106Paul R. Hanson · Materia, Inc. · R42 · FY2016 · GM
Screening and Development of Small Molecule HDAC11 Inhibitors to Treat Obesity and Diabetes.
$538,105Timothy McKinsey · University Of Colorado Denver · R01 · FY2021 · DK
Role of Forkhead proteins in insulin action
$538,099Domenico Accili · Columbia University Health Sciences · R01 · FY2024 · DK
Pharmaceutical Sciences Core
$538,085Vincent Jo Davisson · Brigham And Women'S Hospital · U54 · FY2022 · NS
Genetic Determinants of Epilepsy in Murine Systems
$538,050Wayne N. Frankel · Jackson Laboratory · R01 · FY2007 · NS
STEREOSELECTIVE ATOM-TRANSFER REDOX PROCESSES
$538,037Scripps Research Institute · R01 · FY2002 · GM
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
$538,034Patrice Mimche · University Of Utah · R01 · FY2024 · DK
Scott & White Community Clinical Oncology Program
$537,993Lucas Wong · Scott And White Memorial Hospital · U10 · FY2012 · CA
CORE BIOLOGY AND SYNTHESIS FACILITIES
$537,958Mukund P. Sibi · North Dakota State University · P20 · FY2009 · RR